Metraipolis › archive › dc_03f8024b139e

Clinical Outcomes After Same-Agent Double-Dose Anti-VEGF Escalation in Eyes with a Suboptimal Response to Standard-Dose Treatment for Exudative Macular… — Europe PMC PMID:42590000

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42590000
DOI
10.3390/jcm15155898
License (as archived)
solo-consultazione
Archived
2026-10-07T18:04:37.200Z
SHA-256 of the archived text
c0e07f003ea949f8ebb6b41ab46cd7a2857edb7ecb68c93806a9ae50257b4dd6
Stable URL of this page
https://metraipolis.com/documento/dc_03f8024b139e

How to cite

Clinical Outcomes After Same-Agent Double-Dose Anti-VEGF Escalation in Eyes with a Suboptimal Response to Standard-Dose Treatment for Exudative Macular… — Europe PMC PMID:42590000 — Europe PMC (en), https://europepmc.org/article/MED/42590000 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_03f8024b139e (Metraipolis archive dc_03f8024b139e, sha256 c0e07f003ea949f8ebb6b41ab46cd7a2857edb7ecb68c93806a9ae50257b4dd6)
BibTeX
@misc{dc03f8024b139e,
  title = {Clinical Outcomes After Same-Agent Double-Dose Anti-VEGF Escalation in Eyes with a Suboptimal Response to Standard-Dose Treatment for Exudative Macular… — Europe PMC PMID:42590000},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42590000},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_03f8024b139e; sha256 c0e07f003ea949f8ebb6b41ab46cd7a2857edb7ecb68c93806a9ae50257b4dd6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42590000. Agents can read the archived copy with the MCP tool read_document.